Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Psoriatic Arthritis : At a Glance
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects both the skin and joints, typically developing in individuals with psoriasis. Characterized by joint pain, stiffness, and swelling, PsA can lead to significant disability if not properly managed. It presents in various forms, including symmetrical arthritis, asymmetrical oligoarthritis, and spondylitis, each with distinct clinical features. Early diagnosis is crucial to prevent joint damage and maintain quality of life, as PsA can be progressive and debilitating.
Management of Psoriatic Arthritis involves a combination of treatments aimed at controlling inflammation, reducing pain, and improving joint function. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used for mild cases, while disease-modifying antirheumatic drugs (DMARDs) and biologics, such as TNF inhibitors and IL-17 inhibitors, are crucial for more severe cases. Biologics have revolutionized PsA treatment by targeting specific immune pathways involved in the disease process, offering significant improvements in both skin and joint symptoms. Regular monitoring and a multidisciplinary approach are essential to address the diverse manifestations of PsA and to adjust treatment as needed for optimal patient outcomes.
See More Webinars @ Hidoc Webinars
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation